Bridgeway Capital Management’s Histogen Inc. Common Stock HSTO Stock Holding History
Bought
Maintained
Sold
Other funds holding HSTO
JC
UCFA
QP
Bridgeway Capital Management's HSTO Position: Q1 2020 in Review
Bridgeway Capital Management sold out of Histogen Inc. Common Stock (HSTO) in Q1 2020, closing a stake of 98 shares — an estimated $8K sold.
Bridgeway Capital Management first reported a position in HSTO in Q1 2014 and held it in 24 quarters. The position peaked at $800K in Q1 2018. 27 funds tracked by Wall St. Rank hold HSTO as of Q1 2020.
- Bridgeway Capital Management reported no remaining Histogen Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
- Bridgeway Capital Management sold 98 Histogen Inc. Common Stock shares in Q1 2020, an estimated $8K.
- Bridgeway Capital Management first reported a position in Histogen Inc. Common Stock in Q1 2014 and held it in 24 quarters.
- Bridgeway Capital Management's Histogen Inc. Common Stock position peaked at $800K in Q1 2018.
- 27 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q1 2020.
Based on Bridgeway Capital Management's 13F filing for Q1 2020, filed 15 May 2020.